Business
UK contract for COVID-19 sample collection kits
UK contract for COVID-19 sample collection kits.
About this update from Ekf Diagnostics Holdings Plc
[{"type":"text","content":"\n \n \n RNS Number : 2370L\n EKF Diagnostics Holdings PLC\n 29 April 2020\n \n \n \n \n This announcement contains inside information\nfor the purposes of Article 7 of Regulation (EU) No 596/2014 (MAR)\n \n \n \n \n \n EKF Diagnostics Holdings plc\n \n \n (\"EKF\", the \"Company\" or the \"Group\")\n \n \n \n \n \n UK supply contract for COVID-19 sample collection kits\n \n \n Source BioScience to use PrimeStore MTM kits for COVID-19 testing service\n \n \n \n \n \n EKF Diagnostics Holdings plc (AIM: EKF), the AIM quoted point-of-care business, announces that it has signed an agreement with Source BioScience UK Ltd (\"Source BioScience\"), which provides Laboratory testing services for the NHS, to supply PrimeStore MTM, a novel patented sample collection device, to be used for its growing COVID-19 testing service.\n \n \n \n \n \n Yesterday, the Company announced that is in the final stages of establishing a UK production line for the PrimeStore MTM sample collection kits at its site in Penarth, South Wales, to meet increasing demand. The Penarth site is expected to produce 12,500 sample collection tubes a day once normal production is established, with smaller early batch volumes expected to be shipped to Source BioScience next month.\n \n \n \n \n \n Source BioScience, which provides ISO:15189 Laboratory testing services for the NHS and private healthcare, is working with a number of businesses providing them COVID-19 testing services of their staff to allow business to bring back staff who may be self-isolating due to concerns over infection or infection of a family member. Being able to use the PrimeStore MTM transport media allows a significant benefit of removing the cold chain transportation that is a necessary protocol for other transport media.\n \n \n \n \n \n EKF is a contract manufacturer for the PrimeStore MTM sample collection device, an FDA-approved and CE-marked device owned and created by Longhorn Vaccines and Diagnostics LLC (\"Longhorn\"), a US company. PrimeStore MTM deactivates viruses, bacteria, fungi and mycobacterium tuberculosis allowing safe sample handling and transport, greatly reducing risk of infection. The device was invented in 2006 in preparation for a worldwide pandemic and is designed to de-activate pathogen rapidly and stabilise the RNA for up t...